Envestnet Asset Management Inc Jazz Pharmaceuticals PLC Transaction History

Envestnet Asset Management Inc

  • $302 Billion
  • Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Envestnet Asset Management Inc holds 66,299 shares of JAZZ stock, worth $8.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
66,299
Previous 64,096 3.44%
Holding current value
$8.07 Million
Previous $6.84 Million 8.03%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$100.57 - $116.37 $221,555 - $256,363
2,203 Added 3.44%
66,299 $7.39 Million
Q2 2024

Aug 08, 2024
BUY
$103.94 - $118.98 $64,338 - $73,648
619 Added 0.98%
64,096 $6.84 Million
Q1 2024

May 13, 2024
BUY
$115.19 - $132.77 $644,718 - $743,113
5,597 Added 9.67%
63,477 $7.64 Million
Q4 2023

Feb 13, 2024
SELL
$114.26 - $136.0 $409,393 - $487,288
-3,583 Reduced 5.83%
57,880 $7.12 Million
Q3 2023

Nov 13, 2023
BUY
$122.0 - $145.31 $2.17 Million - $2.58 Million
17,758 Added 40.63%
61,463 $7.96 Million
Q2 2023

Aug 04, 2023
SELL
$122.5 - $147.16 $57.7 Million - $69.3 Million
-470,949 Reduced 91.51%
43,705 $5.42 Million
Q1 2023

May 11, 2023
BUY
$133.98 - $160.47 $62.1 Million - $74.3 Million
463,213 Added 900.47%
514,654 $75.3 Million
Q4 2022

Feb 07, 2023
BUY
$129.72 - $159.85 $227,399 - $280,217
1,753 Added 3.53%
51,441 $8.2 Million
Q3 2022

Nov 10, 2022
BUY
$126.59 - $161.18 $451,419 - $574,767
3,566 Added 7.73%
49,688 $6.62 Million
Q2 2022

Aug 03, 2022
BUY
$141.59 - $168.66 $728,622 - $867,924
5,146 Added 12.56%
46,122 $7.2 Million
Q1 2022

May 04, 2022
BUY
$129.64 - $160.7 $30,983 - $38,407
239 Added 0.59%
40,976 $6.38 Million
Q4 2021

Feb 04, 2022
SELL
$119.87 - $145.67 $172,373 - $209,473
-1,438 Reduced 3.41%
40,737 $5.19 Million
Q3 2021

Oct 07, 2021
SELL
$128.64 - $184.79 $576,821 - $828,598
-4,484 Reduced 9.61%
42,175 $5.49 Million
Q2 2021

Aug 04, 2021
BUY
$160.2 - $186.42 $118,868 - $138,323
742 Added 1.62%
46,659 $8.29 Million
Q1 2021

May 04, 2021
SELL
$150.19 - $173.5 $128,262 - $148,169
-854 Reduced 1.83%
45,917 $7.55 Million
Q4 2020

Feb 02, 2021
SELL
$140.71 - $165.05 $3.34 Million - $3.92 Million
-23,737 Reduced 33.67%
46,771 $7.72 Million
Q3 2020

Oct 09, 2020
SELL
$105.46 - $144.13 $1.48 Million - $2.03 Million
-14,051 Reduced 16.62%
70,508 $10.1 Million
Q2 2020

Jul 08, 2020
BUY
$95.68 - $121.88 $227,144 - $289,343
2,374 Added 2.89%
84,559 $9.33 Million
Q1 2020

Apr 23, 2020
BUY
$87.74 - $152.74 $2.2 Million - $3.83 Million
25,052 Added 43.85%
82,185 $8.2 Million
Q4 2019

Feb 11, 2020
BUY
$117.65 - $153.73 $145,180 - $189,702
1,234 Added 2.21%
57,133 $8.53 Million
Q3 2019

Oct 17, 2019
BUY
$125.18 - $143.24 $862,365 - $986,780
6,889 Added 14.06%
55,899 $7.16 Million
Q2 2019

Aug 02, 2019
BUY
$125.55 - $144.48 $470,686 - $541,655
3,749 Added 8.28%
49,010 $6.99 Million
Q1 2019

May 10, 2019
BUY
$121.81 - $142.95 $791,277 - $928,603
6,496 Added 16.76%
45,261 $6.47 Million
Q4 2018

Feb 13, 2019
BUY
$115.94 - $166.74 $4.49 Million - $6.46 Million
38,765 New
38,765 $4.81 Million
Q3 2018

Nov 14, 2018
SELL
$161.01 - $180.57 $832,582 - $933,727
-5,171 Closed
0 $0
Q2 2018

Aug 10, 2018
BUY
$146.33 - $183.18 $647,217 - $810,205
4,423 Added 591.31%
5,171 $891,000
Q1 2018

May 09, 2018
SELL
$135.59 - $157.16 $20,202 - $23,416
-149 Reduced 16.61%
748 $112,000
Q4 2017

Feb 20, 2018
SELL
$131.06 - $150.39 $14,023 - $16,091
-107 Reduced 10.66%
897 $121,000
Q3 2017

Nov 13, 2017
BUY
$142.62 - $155.6 $1,426 - $1,556
10 Added 1.01%
1,004 $147,000
Q2 2017

Aug 14, 2017
BUY
N/A
994
994 $153,000

Others Institutions Holding JAZZ

# of Institutions
511
Shares Held
57.8M
Call Options Held
188K
Put Options Held
133K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.63B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email